Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Avacta Group

    Client Virtual Booth

    AVACTA GROUP

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Avacta Group
    unitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Unit 20, Ash Way Thorp Arch Estate, Wetherby LS23 7FA
    Telephone
    Telephone
    +44 (0)1904 21 7070
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://avacta.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/avacta-group-plc
    Twitter
    Twitter
    https://twitter.com/affimers?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Avacta Group - AVA6000 Abstract Release by AACR and Full Presentation Update
    Avacta Group - AVA6000 Abstract Release by AACR and Full Presentation Update

    https://www.globenewswire.com/news-release/2024/04/05/2858739/0/en/Avacta-Group-AVA6000-Abstract-Release-by-AACR-and-Full-Presentation-Update.html

    GLOBENEWSWIRE
    05 Apr 2024
    Share Share
    Updated Results from Single-Agent Phase 1 of Peptide Drug Conjugate, AVA6000
    Updated Results from Single-Agent Phase 1 of Peptide Drug Conjugate, AVA6000

    https://www.globenewswire.com//news-release/2024/03/05/2840928/0/en/Updated-Results-from-Single-Agent-Phase-1-Clinical-Trial-of-Peptide-Drug-Conjugate-AVA6000-to-be-Presented-in-a-Poster-at-the-American-Association-of-Cancer-Research-AACR-Annual-Me.html

    GLOBENEWSWIRE
    05 Mar 2024
    Share Share
    Appointment of Chief Business Officer
    Appointment of Chief Business Officer

    https://www.globenewswire.com//news-release/2023/12/19/2798406/0/en/Appointment-of-Chief-Business-Officer.html

    GLOBENEWSWIRE
    19 Dec 2023
    Share Share
    ALS-6000-101 Phase 1a Three-Weekly Dose Escalation Safety Study Data
    ALS-6000-101 Phase 1a Three-Weekly Dose Escalation Safety Study Data

    https://www.globenewswire.com//news-release/2023/12/13/2795421/0/en/ALS-6000-101-Phase-1a-Three-Weekly-Dose-Escalation-Safety-Study-Data.html

    GLOBENEWSWIRE
    13 Dec 2023
    Share Share
    Avacta to present promising new data from Affimer
    Avacta to present promising new data from Affimer

    https://www.globenewswire.com//news-release/2023/10/05/2755071/0/en/Avacta-to-present-promising-new-data-from-Affimer-and-pre-CISIONTM-platform-assets-at-AACR-NCI-EORTC-International-Conference-on-Molecular-Targets-and-Cancer-Therapeutics.html

    GLOBENEWSWIRE
    05 Oct 2023
    Share Share
    Avacta Announces Successful Completion of Fifth Dose Escalation in AVA6000
    Avacta Announces Successful Completion of Fifth Dose Escalation in AVA6000

    https://www.businesswire.com/news/home/20230621749596/en

    BUSINESSWIRE
    21 Jun 2023
    Share Share
    Avacta enrolls fifth patient in cohort of AVA6000 phase Ia dose escalation study
    Avacta enrolls fifth patient in cohort of AVA6000 phase Ia dose escalation study

    http://www.pharmabiz.com/NewsDetails.aspx?aid=157418&sid=2

    PHARMABIZ
    08 Apr 2023
    Share Share
    Avacta Opens First Two US Clinical Investigator Sites for AVA6000 Phase 1 Study
    Avacta Opens First Two US Clinical Investigator Sites for AVA6000 Phase 1 Study

    https://www.businesswire.com/news/home/20230406005353/en

    BUSINESSWIRE
    06 Apr 2023
    Share Share
    Avacta Announces First Patient Dosed in Cohort of AVA6000 PhIa Escalation Study
    Avacta Announces First Patient Dosed in Cohort of AVA6000 PhIa Escalation Study

    https://www.businesswire.com/news/home/20230405005422/en

    BUSINESSWIRE
    05 Apr 2023
    Share Share
    Avacta Names Karen Harrison COO for Therapeutics Division
    Avacta Names Karen Harrison COO for Therapeutics Division

    https://www.contractpharma.com/contents/view_breaking-news/2023-03-28/avacta-names-karen-harrison-coo-for-therapeutics-d/?widget=listSection

    CONTRACT PHARMA
    28 Mar 2023
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search